73921-009 NDC - I-DROPS ARTIFICIAL TEARS (HYPROMELLOSE, NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80, ZINC SULFATE)

Drug Information

Product NDC: 73921-009

Proprietary Name: i-Drops ARTIFICIAL TEARS

Non Proprietary Name: Hypromellose, Naphazoline Hydrochloride, Polysorbate 80, Zinc Sulfate

Active Ingredient(s):
  • 2 mg/mL HYPROMELLOSE, UNSPECIFIED;
  • .25 mg/mL NAPHAZOLINE HYDROCHLORIDE;
  • 5 mg/mL POLYSORBATE 80;
  • 2.5 mg/mL ZINC SULFATE, UNSPECIFIED FORM


Administration Route(s): OPHTHALMIC

Dosage Form(s): SOLUTION/ DROPS

Labeler Information

Labeler Name: GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED
Product Type: HUMAN OTC DRUG
FDA Application Number: part349
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date:4/1/2021

Package Information

No. Package Code Package Description Billing Unit
173921-009-151 BOTTLE, DROPPER in 1 CARTON (73921-009-15) > 15 mL in 1 BOTTLE, DROPPER

NDC Record

Field Name Field Value Definition
PRODUCT NDC73921-009The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEi-Drops ARTIFICIAL TEARSThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEHypromellose, Naphazoline Hydrochloride, Polysorbate 80, Zinc SulfateThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEOPHTHALMICThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/1/2021This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERpart349This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGLOBAL PHARMA HEALTHCARE PRIVATE LIMITEDName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEHYPROMELLOSE, UNSPECIFIED; NAPHAZOLINE HYDROCHLORIDE; POLYSORBATE 80; ZINC SULFATE, UNSPECIFIED FORMThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH2; .25; 5; 2.5 
ACTIVE INGRED UNITmg/mL; mg/mL; mg/mL; mg/mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 8/16/2021